SCHEMBL31408437

SCHEMBL31408437

COc1cnc(-c2cc3[nH]c(CNC(=O)N4CC(C#N)C4)cc3cc2Cl)cn1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ JAK2 O60674 4/20 0.33
▸ JAK1 P23458 4/20 0.33
▸ JAK3 P52333 4/20 0.33
▸ LRRK2 Q5S007 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ PDCD1 Q15116 1/20 0.31
▸ CD274 Q9NZQ7 1/20 0.31
▸ METTL3 Q86U44 1/20 0.31
▸ METTL14 Q9HCE5 1/20 0.31
▸ ROCK2 O75116 1/20 0.31
▸ PTGES O14684 1/20 0.31
▸ CCNT1 O60563 2/20 0.31
▸ CDK9 P50750 2/20 0.31
▸ BTK Q06187 2/20 0.30
▸ CHRNA7 P36544 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408537 0.90 SMN1; SMN2 (0.36) SMN1; SMN2JAK2JAK3LRRK2MAPK1
SCHEMBL31408430 0.87 MAPK1 (0.37) SMN1; SMN2MAPK1PTGES
SCHEMBL31408237 0.85 LRRK2 (0.35) SMN1; SMN2JAK2JAK3LRRK2MAPK1
SCHEMBL31408327 0.85 LRRK2 (0.35) SMN1; SMN2JAK2JAK3LRRK2MAPK1
SCHEMBL31408429 0.85 LRRK2 (0.35) SMN1; SMN2JAK2JAK3LRRK2MAPK1
SCHEMBL31408514 0.85 SMN1; SMN2 (0.36) SMN1; SMN2MAPK1PDCD1CD274PTGES
SCHEMBL31408279 0.85 SMN1; SMN2 (0.36) SMN1; SMN2LRRK2MAPK1PTGES
SCHEMBL31408356 0.84 POLB (0.39) SMN1; SMN2LRRK2MAPK1
SCHEMBL31408404 0.84 LRRK2 (0.36) SMN1; SMN2LRRK2MAPK1PDCD1CD274
SCHEMBL31408407 0.83 MAP4K1 (0.35) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback